Clinical Trials Browser

OTHER × Nonseminomatous germ cell tumor × Genitourinary × Clear all

Nonseminomatous germ cell tumor, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Kidney Neoplasms, Melanoma, Neoplasms, Sarcoma

NCT02499952 2022-07-11

Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors

Phase 2 Terminated

12 enrolled 14 charts

GenitourinaryGynecologic

Nonseminomatous germ cell tumor, Genital Neoplasms, Female, Genital Neoplasms, Male, Mediastinal Neoplasms, Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Testicular Neoplasms

NCT02689219 2019-12-10

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

Phase 2 Terminated

18 enrolled 13 charts

Genitourinary

Nonseminomatous germ cell tumor, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Carcinoma, Embryonal

Clinical Trials

DP-PAN-CANCER

Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors